Dyspepsia

Uninvestigated dyspepsia

Dyspepsia denotes a symptom and not a disease. It is a short-term problem in the majority of patients.


Antacids.

Co-magaldrox
Co-magaldrox 195mg/220mg/5ml oral suspension sugar free

Alginates. Please note there is a lower dosage advised for Gaviscon Advance products compared to Peptac.

Sodium alginate + Potassium bicarbonate
Gaviscon Advance oral suspension aniseed
Gaviscon Advance oral suspension peppermint
Gaviscon Advance Mint chewable tablets
Calcium carbonate + Sodium alginate + Sodium bicarbonate
Peptac liquid aniseed
Peptac liquid peppermint

Proton pump inhibitors.

Omeprazole
Omeprazole 10mg gastro-resistant capsules
Omeprazole 20mg gastro-resistant capsules
Lansoprazole
Lansoprazole 15mg gastro-resistant capsules
Lansoprazole 30mg gastro-resistant capsules

Lansoprazole orodispersible tablets are for use only in patients with swallowing difficulties, or for administration via nasogastric or percutaneous endoscopic gastrostomy tube.

Lansoprazole
Lansoprazole 15mg orodispersible tablets
Lansoprazole 30mg orodispersible tablets

Prescribing Notes:

  • Lifestyle changes are often required, such as raising the head of the bed, weight reduction, reduction of alcohol, smoking cessation and avoidance of aggravating foods.
  • Compound alginic acid preparations are less powerful antacids than co-magaldrox but may be more effective for heartburn.
  • PPIs are most effective when taken on an empty stomach, 20-30 minutes before breakfast.
  • One week’s treatment may be sufficient to determine if dyspepsia will respond and whether it is self-limiting.
  • Antacids should be used for 10-14 days when withdrawing PPI treatment, to help with rebound symptoms. PPIs should be used with caution in the elderly. There may be an association between PPI use and Clostridioides difficile (C.diff) infection and osteoporosis. Careful consideration should be made to the risk benefit ratio.
  • Antacids, taken at the same time as other drugs, may impair their absorption. They may also damage enteric coatings designed to prevent irritant drugs from dissolving in the stomach.

History Notes

15/04/2026

Regional formulary chapter launched.

NSAID-associated ulcers and dyspepsia

If NSAID-induced gastro-intestinal bleeding or ulceration occurs the NSAID should ideally be stopped, and omeprazole or lansoprazole prescribed.


Omeprazole capsules should be prescribed rather than tablets, as tablets are more expensive with no additional benefit.

Omeprazole
Omeprazole 20mg gastro-resistant capsules
Lansoprazole
Lansoprazole 15mg gastro-resistant capsules
Lansoprazole 30mg gastro-resistant capsules

Prescribing Notes:

  • Lansoprazole orodispersible tablets should be reserved for patients with swallowing difficulties or who require a proton pump inhibitor via nasogastric (NG) or percutaneous endoscopic gastrostomy (PEG) tube. Lansoprazole orodispersible tablets are preferred to omeprazole dispersible tablets.
  • PPIs are most effective when taken on an empty stomach, 20-30 minutes before breakfast.
  • Patients receiving low dose aspirin 75mg daily, who are at risk of NSAID-associated ulcers, should be prescribed a proton pump inhibitor concomitantly instead of replacing aspirin with clopidogrel.
  • PPIs should be used with caution in the elderly. There may be an association between PPI use and Clostridioides difficile (C.diff) infection and osteoporosis. Careful consideration should be made to the risk benefit ratio.
  • Step down treatment from 20mg omeprazole daily (or equivalent), or "on demand treatment" may be appropriate when symptoms are controlled.
  • Stepping down treatment is NOT appropriate for the following groups:
    • People with complicated oesophagitis (LA Grade C & D).
    • People taking PPI for gastroprotection against NSAID.
    • Those with a previous bleeding peptic ulcer, remaining H. pylori positive after at least 2 eradication attempts.
  • Patients should have:
    • 2 weeks off PPI and 4 weeks off antibiotics prior to H. pylori faecal antigen test or breath test;
    • Antacids/alginates are the preferred treatment during this period;
    • Patients on PPIs are encouraged to increase their intake of dietary calcium.

History Notes

15/04/2026

Regional formulary chapter launched.

Heartburn in pregnancy

Antacids.

Co-magaldrox
Co-magaldrox 195mg/220mg/5ml oral suspension sugar free

Alginates. Please note there is a lower dosage advised for Gaviscon Advance products compared to Peptac.

Sodium alginate + Potassium bicarbonate
Gaviscon Advance oral suspension aniseed
Gaviscon Advance oral suspension peppermint
Gaviscon Advance Mint chewable tablets
Calcium carbonate + Sodium alginate + Sodium bicarbonate
Peptac liquid aniseed
Peptac liquid peppermint

History Notes

15/04/2026

Regional formulary chapter launched.

Pharmacy First – Dyspepsia
Co-magaldrox
Co-magaldrox 195mg/220mg/5ml oral suspension sugar free
Calcium carbonate + Sodium alginate + Sodium bicarbonate
Peptac liquid aniseed
Peptac liquid peppermint

History Notes

15/04/2026

Regional formulary chapter launched.